help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Petrik, J.
Right arrow Articles by Hill, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petrik, J.
Right arrow Articles by Hill, D. J.
Endocrinology Vol. 140, No. 5 2353-2363
Copyright © 1999 by The Endocrine Society

ARTICLES

Overexpression of Insulin-Like Growth Factor-II in Transgenic Mice Is Associated with Pancreatic Islet Cell Hyperplasia1

J. Petrik, J. M. Pell, E. Arany, T. J. McDonald, W. L. Dean, W. Reik and D. J. Hill

Lawson Research Institute (J.P., E.A., T.J.M., D.J.H.), St. Joseph’s Health Centre, London, Ontario, N6A 4V2, Canada; Departments of Physiology (J.P., D.J.H.), Medicine (E.A., T.J.M., D.J.H.), Paediatrics (J.P., D.J.H.), Pharmacology and Toxicology (T.J.M.), and Biochemistry (T.J.M.), University of Western Ontario, London, Ontario, N6A 5A5, Canada; and Laboratory of Developmental Genetics and Imprinting (J.M.P., W.L.D., W.R.), The Babraham Institute, Cambridge CB2 4AT, United Kingdom

Address all correspondence and requests for reprints to: Dr. D. J. Hill, Lawson Research Institute, St. Joseph’s Health Centre, 268 Grosvenor Street, London, Ontario, Canada, N6A 4V2. E-mail: dhill{at}lri.stjosephs.london.on.ca

We have used an insulin-like growth factor (IGF)-II transgenic mouse model in which mouse IGF-II is widely overexpressed, resulting in increased fetal size and selective organ overgrowth, to investigate the effects on the development of the endocrine pancreas. Fetuses examined on day 19.5–20 of gestation had significantly elevated circulating levels of IGF-II, compared with control mice. The pancreatic islets in transgenic animals were of irregular shape and had a mean area five times greater than in controls, whereas the mean number of islets per tissue section was not altered. The size of individual endocrine cells was not altered. Although the islets in animals expressing the IGF-II transgene were considerably larger, immunohistochemistry for insulin and glucagon showed that the relative proportion of ß-cells was significantly less, and that of {alpha}-cells was higher. Normal islet morphology was disrupted, with {alpha}-cells appearing in small groups within the islets, as well as on the periphery, whereas ß-cells were often seen at the edge of the islets. Twice as many islet cells (21.9% vs. 11.4%) were involved in cell replication, detected by the presence of immunoreactive proliferating cell nuclear antigen, in pancreata from transgenic mice vs. controls, whereas the number of cells undergoing apoptosis was significantly reduced. Abundant IGF-II messenger RNA was found within the islets of transgenic animals by in situ hybridization, and the relative area of islets demonstrating immunoreactive IGF-II was significantly greater. Immunoreactive IGF-I was much less abundant and was further reduced in islets of transgenic animals. The area of islets immunopositive for IGF binding protein-2 was unaltered. Despite the presence of islet hyperplasia, circulating insulin levels and serum glucose levels were not significantly different between transgenic and control mice. These results show that an overexpression of IGF-II in fetal life has a profound effect on islet morphology and causes islet hyperplasia while reducing the attrition of islet cells by apoptosis.




This article has been cited by other articles:


Home page
 J. Lipid Res.Home page
D. Gniuli, A. Calcagno, M. E. Caristo, A. Mancuso, V. Macchi, G. Mingrone, and R. Vettor
Effects of high-fat diet exposure during fetal life on type 2 diabetes development in the progeny
J. Lipid Res., September 1, 2008; 49(9): 1936 - 1945.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
M. P. Keller, Y. Choi, P. Wang, D. Belt Davis, M. E. Rabaglia, A. T. Oler, D. S. Stapleton, C. Argmann, K. L. Schueler, S. Edwards, et al.
A gene expression network model of type 2 diabetes links cell cycle regulation in islets with diabetes susceptibility
Genome Res., May 1, 2008; 18(5): 706 - 716.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. M. Bonaventura, P. N. Catalano, A. Chamson-Reig, E. Arany, D. Hill, B. Bettler, F. Saravia, C. Libertun, and V. A. Lux-Lantos
GABAB receptors and glucose homeostasis: evaluation in GABAB receptor knockout mice
Am J Physiol Endocrinol Metab, January 1, 2008; 294(1): E157 - E167.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
A. M Ackermann and M. Gannon
Molecular regulation of pancreatic {beta}-cell mass development, maintenance, and expansion
J. Mol. Endocrinol., February 1, 2007; 38(2): 193 - 206.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
H. Jiang, H. Zhu, X. Chen, Y. Peng, J. Wang, F. Liu, S. Shi, B. Fu, Y. Lu, Q. Hong, et al.
TIMP-1 Transgenic Mice Recover From Diabetes Induced by Multiple Low-Dose Streptozotocin
Diabetes, January 1, 2007; 56(1): 49 - 56.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
I. Giurgea, C. Sempoux, C. Bellanne-Chantelot, M. Ribeiro, L. Hubert, N. Boddaert, J.-M. Saudubray, J.-J. Robert, F. Brunelle, J. Rahier, et al.
The Knudson's Two-Hit Model and Timing of Somatic Mutation May Account for the Phenotypic Diversity of Focal Congenital Hyperinsulinism
J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 4118 - 4123.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
P. M. Vuguin, M. H. Kedees, L. Cui, Y. Guz, R. W. Gelling, M. Nejathaim, M. J. Charron, and G. Teitelman
Ablation of the Glucagon Receptor Gene Increases Fetal Lethality and Produces Alterations in Islet Development and Maturation
Endocrinology, September 1, 2006; 147(9): 3995 - 4006.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Iwakura, K. Hosoda, C. Son, J. Fujikura, T. Tomita, M. Noguchi, H. Ariyasu, K. Takaya, H. Masuzaki, Y. Ogawa, et al.
Analysis of Rat Insulin II Promoter-Ghrelin Transgenic Mice and Rat Glucagon Promoter-Ghrelin Transgenic Mice
J. Biol. Chem., April 15, 2005; 280(15): 15247 - 15256.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. A. McCann, Y. Q. Xu, R. Frechette, L. Guazzarotti, and C. Polychronakos
The Insulin-Like Growth Factor-II Receptor Gene Is Associated with Type 1 Diabetes: Evidence of a Maternal Effect
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5700 - 5706.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
E. A. Joanette, B. Reusens, E. Arany, S. Thyssen, R. C. Remacle, and D. J. Hill
Low-Protein Diet during Early Life Causes a Reduction in the Frequency of Cells Immunopositive for Nestin and CD34 in Both Pancreatic Ducts and Islets in the Rat
Endocrinology, June 1, 2004; 145(6): 3004 - 3013.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
W. R. Bennett, T. E. Crew, J. M. W. Slack, and A. Ward
Structural-proliferative units and organ growth: effects of insulin-like growth factor 2 on the growth of colon and skin
Development, March 15, 2003; 130(6): 1079 - 1088.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. Sempoux, Y. Guiot, K. Dahan, P. Moulin, M. Stevens, V. Lambot, P. d. Lonlay, J.-C. Fournet, C. Junien, F. Jaubert, et al.
The Focal Form of Persistent Hyperinsulinemic Hypoglycemia of Infancy: Morphological and Molecular Studies Show Structural and Functional Differences With Insulinoma
Diabetes, March 1, 2003; 52(3): 784 - 794.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Cebrian, A. Garcia-Ocana, K. K. Takane, D. Sipula, A. F. Stewart, and R. C. Vasavada
Overexpression of Parathyroid Hormone-Related Protein Inhibits Pancreatic {beta}-Cell Death In Vivo and In Vitro
Diabetes, October 1, 2002; 51(10): 3003 - 3013.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
B. Duvillie, C. Currie, T. Chrones, D. Bucchini, J. Jami, R. L. Joshi, and D. J. Hill
Increased Islet Cell Proliferation, Decreased Apoptosis, and Greater Vascularization Leading to {beta}-Cell Hyperplasia in Mutant Mice Lacking Insulin
Endocrinology, April 1, 2002; 143(4): 1530 - 1537.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. Nakae, Y. Kido, and D. Accili
Distinct and Overlapping Functions of Insulin and IGF-I Receptors
Endocr. Rev., December 1, 2001; 22(6): 818 - 835.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. A. Kassem, I. Ariel, P. S. Thornton, K. Hussain, V. Smith, K. J. Lindley, A. Aynsley-Green, and B. Glaser
p57KIP2 Expression in Normal Islet Cells and in Hyperinsulinism of Infancy
Diabetes, December 1, 2001; 50(12): 2763 - 2769.
[Abstract] [Full Text] [PDF]

Home page
 Br Med BullHome page
C. E Bertram and M. A Hanson
Animal models and programming of the metabolic syndrome: Type 2 diabetes
Br. Med. Bull., November 1, 2001; 60(1): 103 - 121.
[Abstract] [Full Text] [PDF]

Home page
 Br Med BullHome page
A. L Fowden and D. J Hill
Intra-uterine programming of the endocrine pancreas
Br. Med. Bull., November 1, 2001; 60(1): 123 - 142.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
B. Tyrberg, J. Ustinov, T. Otonkoski, and A. Andersson
Stimulated Endocrine Cell Proliferation and Differentiation in Transplanted Human Pancreatic Islets: Effects of the ob Gene and Compensatory Growth of the Implantation Organ
Diabetes, February 1, 2001; 50(2): 301 - 307.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
D. J. Hill, B. Strutt, E. Arany, S. Zaina, S. Coukell, and C. F. Graham
Increased and Persistent Circulating Insulin-Like Growth Factor II in Neonatal Transgenic Mice Suppresses Developmental Apoptosis in the Pancreatic Islets
Endocrinology, March 1, 2000; 141(3): 1151 - 1157.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society